Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDizzy spells on Mounjaro are reported by some people, particularly in the early weeks of treatment or after a dose increase. They are usually mild and short-lived, most often linked to dehydration, drops in blood pressure when standing, or reduced food intake rather than a direct toxic effect of tirzepatide itself. That said, dizziness can occasionally signal something that needs prompt attention, so it is worth understanding what is typical and what is not. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber reviews whether it is suitable for you before treatment begins, and that prescriber should hear about any symptoms that concern you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Yes, dizziness appears in the side-effect data for tirzepatide, and if you want a thorough look at why tirzepatide can cause dizziness and what drives it, the picture is more nuanced than a simple pharmacological effect. Tirzepatide slows gastric emptying and reduces appetite significantly, so two very ordinary knock-on effects follow: people eat and drink less than usual, and blood pressure can fall slightly, especially when moving from sitting or lying to standing.
That blood-pressure change (postural hypotension) is a well-documented companion of GLP-1 receptor agonists. Your cardiovascular system gets a small vasodilatory nudge from the medicine, and if your fluid intake has also dropped because nausea is putting you off drinking, the two effects combine. The result is that standing up quickly can make the room tip briefly. Most people find this settles as their body adapts to tirzepatide over a few weeks.
There is a quick checking habit worth building into your day: every morning before you get out of bed, sit upright on the edge of the mattress for a full thirty seconds before standing. If that simple pause stops the dizziness, postural hypotension is the likely culprit, and steady hydration across the day is the first fix to try. If it makes no difference, the cause is probably something else and worth mentioning to your prescriber.
The Mounjaro dosing schedule starts at 2.5 mg, a level chosen to give your digestive system time to adjust before the therapeutic doses begin. Each step up (2.5 mg to 5 mg, then 7.5 mg and beyond) repeats that adjustment process in miniature. Nausea and reduced appetite typically spike again in the first one to two weeks after each increase, which means fluid and calorie intake often dip at exactly those moments.
That temporary dip is the most common explanation for why dizziness flares after a dose step up even in people who had no trouble at the previous level. The practical implication: pay closer attention to water intake in the week following any increase. Small, regular sips throughout the day tend to work better than trying to catch up with large drinks when you already feel off. Electrolyte-containing drinks can help if nausea is severe enough to affect your appetite for food as well.
If you take medication for high blood pressure alongside Mounjaro, it is worth flagging any new or worsening dizziness to your prescriber early. The blood-pressure-lowering effects of both can overlap, and your antihypertensive dose may need reviewing as your weight changes on treatment.
Most dizzy spells linked to Mounjaro are transient and positional — they pass within seconds and have an obvious trigger such as standing quickly or having eaten very little that day. Some situations are different and need prompt medical attention.
Call 999 or go to A&E if dizziness is accompanied by chest pain, palpitations, sudden one-sided weakness or slurred speech, or a loss of consciousness. These are not typical Mounjaro side effects and need emergency assessment regardless of what medicine you are taking.
Contact your GP or a clinician the same day if: the dizziness is severe and does not resolve with rest and fluids; you have fainted or nearly fainted more than once; or the dizziness is new and persistent rather than a brief postural symptom. Severe, unrelenting stomach pain that radiates to the back (particularly with vomiting) needs urgent assessment too; the MHRA Yellow Card scheme asks that any serious suspected side effects of prescription medicines are reported, and your prescriber can guide you through that process.
Dehydration serious enough to affect kidney function is a risk when nausea causes persistent vomiting; signs include very dark urine, extreme thirst and confusion. If you reach that point, do not wait, get medical help that day.
Hydration is the single most effective lever most people have. Aim for consistent fluid intake across the day rather than large volumes in one go, which can itself worsen nausea. If plain water is unappealing because of how you feel, diluted juice or clear broth counts. The goal is pale, straw-coloured urine; anything darker suggests you need more fluid.
Food timing matters too. Smaller, more frequent meals (with a focus on protein and fibre) tend to be better tolerated and help keep blood sugar and blood pressure steadier than one or two large meals. The tirzepatide treatment overview covers the broader lifestyle adjustments that tend to support Mounjaro well.
Alcohol amplifies the dehydration and blood-pressure effects of tirzepatide, so it is worth moderating it, particularly in the early weeks. For a fuller explanation of how Mounjaro can make you dizzy and what you can do about it, move from lying to sitting, pause, then to standing, rather than going straight from horizontal to upright.
If dizzy spells are persistent enough to affect your daily life or make you nervous about treatment, speak to a prescriber before adjusting or stopping your dose. The nume FAQs address common questions about managing side effects. For a detailed review of how Mounjaro treatment is structured and what private treatment involves, see our Mounjaro cost and service page. When you are ready to talk to a prescriber directly, starting a free consultation is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.